Data & APIs
Events
Cannabis
Marketfy
Premarket Prep

+

Create your free account

Already have an account? Login

Name:

Email Address:

Password:

Leave blank:

By creating an account, you agree to the
Terms of Service and acknowledge our Privacy Policy.

+

Log in to your account

Email Address:

Password:

Forgot your password?

Don't have a Benzinga account? Create one

Contribute
Login
Join

News
- Earnings
- Guidance
- Dividends
- M&A
- Buybacks
- Legal
- Interviews
- Management
- Retail Sales
- Offerings
- IPOs
- Insider Trades
- Biotech/FDA
- Freight
- Tech
Markets
- Pre-Market
- After Hours
- Movers
- ETFs
- Forex
- Cannabis
- Commodities
- Options
- Binary Options
- Bonds
- Futures
- Global Economics
- Previews
- Reviews
- Small-Cap
- Cryptocurrency
- Penny Stocks
Ratings
Ideas
Fintech
Investing
Cannabis
Education
Premium

Market Overview

Tickers

Articles

Keywords

Search by keyword...

googlecse

More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries

Artelo Biosciences, Inc. (ARTL)

0.93 -0.04 (-4.34%)

Analyst Ratings

Find Analyst Ratings for:

Date	Research Firm	Action	Current	PT
1/07/21	Maxim Group	Upgrades	Buy
5/13/20	Maxim Group	Downgrades	Hold
7/09/19	Maxim Group	Initiates Coverage On	Buy	8.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter

Recent Ratings

INT (Upgrades)
TTWO (Downgrades)
MESO (Downgrades)
ACIA (Downgrades)
CERN (Downgrades)
PINC (Downgrades)
ROIC (Upgrades)
BRX (Upgrades)
SO (Upgrades)
LE (Upgrades)

News Coverage

BofA Upgrades World Fuel Services On Oil Demand, Price Recovery
Why BofA Is Double Downgrading Cerner: 'Not Much Room For Upside'
Why This Enphase Energy Analyst Is Bullish Following Tesla-Driven Sell-Off
The Gilead, Galapagos Pipeline Opportunities That Are Turning Morgan Stanley Bullish
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2021
10 Biggest Price Target Changes For Tuesday
JPMorgan Sees Bitcoin Crossing $40K Again In Coming Weeks, If This Key Condition Is Met
Here's How Americans Are Spending Their Stimulus Payments
JPMorgan Upgrades Hewlett Packard Enterprise On Valuation
Morgan Stanley: Axon Enterprise's Growth 'More Durable' Than Peers

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
News Widget
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Privacy Policy / Do Not Sell My Personal Data
Disclaimer
Service Status
Sitemap

© 2021 Benzinga | All Rights Reserved